VENU Venu Holding Corp Insider Trading

Director Thomas M Finke buys 15,000 VENU shares at $3.74; stock now $2.88, -84.2% from 52-week high, -16.8% in 30 days.

Thomas M Finke, a Director, purchased 15,000 shares at $3.74 on 2026-05-26, increasing his holdings by 50.1% to 44,961 shares. The stock currently trades at $2.88, down 84.2% from its 52-week high of $18.17 and down 16.8% over the past 30 days. His prior buys at VENU (4 prior trades) showed a 0.00% win rate at the 90-day mark, with all four trades followed by losses ranging from -59.8% to -60.0%. Across his broader cross-ticker track record, his 5 prior buys averaged -6.1% over 30 days and -59.8% over 90 days with a 0.00% win rate, suggesting his purchase timing has been consistently unsuccessful. The company is unprofitable, posting a net loss of $-13.8M against revenue of $3.9M in the latest quarter.

CEO ROTH JAW bought 62,500 shares at $4.00 on 2026-03-10; stock now $3.44, down 81.0% from 52-week high of $18.10.

CEO Jay W. Roth purchased 62,500 shares at $4.00 on 2026-03-10, his second open-market buy in the past two months at VENU (prior buy on 2026-01-30 returned -7.2% over 30 days). The stock has traded down 40.2% in the 30 days since and 65.7% over 90 days, currently at $3.44 versus the 52-week high of $18.10. The company is unprofitable with net income of $-6,361,487.00 on revenue of $5,384,754.00 (latest quarter), though it reported annual revenue growth of 41.6% year-over-year. His prior trades at this ticker show a 33% well-timed rate at the 90-day mark; most recently, sells on 2025-06-24 and 2025-06-23 returned +7.3% and +4.1% respectively over 30 days but turned negative at 90 days (-0.8% and -4.7%), suggesting late timing in identifying downturns. The repeated purchases into a steep decline warrant close examination of whether they reflect conviction in recovery or liquidity demands.

VENU CEO Jay Roth buys 4,000 shares at $5.23; stock -71.4% from 52-week high, company unprofitable.

CEO Jay Roth purchased 4,000 shares at $5.23 on 2026-02-20, a modest addition to his 9.25M-share position. The purchase occurs as VENU stock trades $5.17, down 71.4% from its 52-week high of $18.10 and down 43.4% over the prior 30 days. The company is unprofitable (net income of $-6.4M in the latest quarter) despite strong revenue growth of 41.6% year-over-year, signaling execution challenges in reaching profitability. In Roth's same-ticker history at VENU, his prior buy on 2026-01-30 outcomes remain unmeasurable, while his four recent sells (June 2025) posted mixed 90-day results: two showed 0.8% gains and two showed -4.7% declines, with 2 of 4 prior trades well-timed at the 90-day mark. The current purchase at a depressed price point follows earlier accumulation activity this year.

VENU CEO Roth buys 5,000 shares at $5.55 as stock down 69.1% from 52-week high

CEO Jay W. Roth purchased 5,000 shares at $5.55 on 2026-01-30, expanding his holdings to 9,249,644 shares. This open-market purchase occurs as VENU trades at $5.59, down 69.1% from its 52-week high of $18.10 and off 30.0% over the past 30 days. The company remains unprofitable (net income of $-6,361,487.00 for the latest quarter) despite reporting annual revenue growth of 41.6%, which adds ambiguity to the signal. Notably, Roth's prior four trades at VENU were all sales (June 2025), with a 50% rate of well-timed execution at the 90-day mark. This buy represents a reversal from that recent selling pattern, though the magnitude (5,000 shares) is modest relative to his 9.25M share position.

Director Finke bought 4,361 VENU shares at $7.80 on 2025-12-30; stock down 54.6% from 52-week high, after three buys on 2025-12-26.

Finke purchased 4,361 shares at $7.80, adding to holdings at a time when VENU trades 54.6% below its 52-week high and has fallen 24.6% in the last 30 days and 34.5% over 90 days. This buy follows three prior purchases on 2025-12-26 at the same ticker, indicating consecutive accumulation activity. However, Finke's cross-ticker track record shows 4 prior open-market buys with an average 90-day return of -59.3% and a 0.00% win rate, suggesting a pattern of purchasing ahead of further declines rather than inflection points. The company itself remains unprofitable with net income of $-6.4M in the latest quarter, though revenue has grown 41.6% year-over-year.

Director Craddock Matthew bought 285 shares at blended average $8.15; stock now $7.98, down 55.9% from $18.10 high.

Craddock Matthew, a director at Venu Holding Corp, executed 2 separate purchases totaling 285 shares for $2,321.48 on 2025-12-31, increasing his holdings from 75,000 to 75,285 shares (+0.4%). The purchases occurred at a blended average price of $8.15, slightly above the current price of $7.98, and well below the 52-week high of $18.10 where the stock has declined 55.9%. The company is unprofitable with full-year net income of $-6,361,487.00 despite posting annual revenue growth of +41.6%, and most recent quarter revenue was $5,384,754.00. The modest purchase size relative to his existing 75,000-share position and the company's loss-making status provide limited signal strength regarding insider conviction.

Director Finke purchases 600 shares at $8.15–$8.18 amid 56.9% decline from 52-week high; stock unprofitable with net loss of $6.4M.

Thomas M Finke, a director at Venu Holding Corp, executed 3 separate purchases totaling 600 shares for $4,892.00 on 2025-12-26 at prices ranging from $8.13 to $8.18, bringing his holdings to 25,600 shares. This purchase occurs against a challenging backdrop: the stock is currently at $7.80, down 56.9% from its 52-week high of $18.10, and down 22.9% over the prior 30 days and 38.8% over 90 days. Fundamentally, Venu remains unprofitable with a net loss of $6.4M against revenue of $5.4M in the latest quarter, though the company has posted 41.6% annual revenue growth. Finke's cross-ticker track record shows 2 prior buys with a 0.00% 90-day win rate, averaging -59.3% 90-day returns, indicating a pattern of purchases that have not recovered within that horizon.

10% Owner O'Neil Kevin Wayne bought 55,000 shares for $461,720.57 (22 transactions on 2025-11-18) as stock down 46.2% from 52-week high.

O'Neil Kevin Wayne, a 10% owner, executed 22 separate purchases on 2025-11-18 totaling 55,000 shares for $461,720.57 at a blended average price of $8.39, increasing his holdings from 2.08M to 2.13M shares. The purchase occurred as VENU stock traded at $9.74, down 46.2% from its 52-week high of $18.10 and down 26.8% over the past 30 days, suggesting the acquisition occurred at a significantly depressed valuation relative to recent trading range. The company reports negative net income of $-6.4M on quarterly revenue of $5.4M, though annual revenue growth stands at +41.6%, creating tension between top-line momentum and current profitability. This substantial open-market accumulation by a major shareholder during a period of sharp stock price decline warrants attention to whether the insider views the pullback as temporary market dislocation or whether the deteriorating near-term profitability signals deeper operational challenges ahead.

CEO Jay W Roth sells 46,506 shares at avg $13.25; stock now $11.70, down 17.7% from 52-week high.

Jay W Roth (CEO, Chairman) executed 4 separate sales totaling 46,506 shares for $616,086.63 on June 23–24, 2025, at a blended average price of $13.25. The sales reduced his holdings by 4.4% to 1,012,623 shares. The stock has since declined to $11.70, trading 17.7% below its 52-week high of $14.21, suggesting the executive sold near elevated price levels relative to recent weakness. The company is unprofitable (full-year net income was negative) and generated only $718,722.00 revenue in the latest quarter, though it reported 41.6% annual revenue growth. The timing of these sales—just above current price—coincides with the stock's recent strength (30-day and 90-day changes both around 32–33%), but the subsequent decline to current levels indicates the sales occurred before a pullback, without additional context to clarify the reason for the liquidation.